Table 3 Risk of referral from conditional logistic regression for patients referred to a dermatologist
Variable | Immediately referred at diagnosis | Referred >30 days after diagnosis |
|---|---|---|
Adjusted†Odds ratio (95% CI) | Adjusted†Odds ratio (95% CI) | |
Age | 1.00 (0.98-1.00) | 0.99 (0.98-1.00) |
Males | 1.07 (0.92-1.23) | 0.87 (0.71-1.07) |
Number of comorbidities in prior year | 1.01 (0.94-1.08) | 0.96 (0.87-1.06) |
Number of GP visits in prior year | 1.14 (1.08-1.20)* | 1.87 (1.73-2.01)* |
Psoriatic arthritis at index | 1.16 (0.62-2.19) | 1.15 (0.61-2.16) |
No psoriasis-related prescription at index | Reference | NA |
Corticosteroid prescription at index | 1.56 (1.26-1.92)* | NA |
Vitamin D3 analogue prescription at index | 1.84 (1.50-2.25)* | NA |
Tar & tar combination prescription at index | 2.00 (1.45-2.76)* | NA |
Non-biologic systemic therapy at index | 0.30 (0.11-0.88)* | NA |
No psoriasis-related prescription in 30 days prior to referral | NA | Reference |
Corticosteroid prescription in 30 days prior to referral | NA | 2.43 (1.45-4.07)* |
Vitamin D3 analogue prescription in 30 days prior to referral | NA | 4.67 (2.78-7.84)* |
Tar & tar combination prescription in 30 days prior to referral | NA | 1.95 (1.02-3.75)* |
Non-biologic systemic therapy in 30 days prior to referral | NA | 0.20 (0.05-0.90)* |
Number of psoriasis-related prescriptions in 30 days prior to referral | NA | 0.85 (0.31-1.17) |